INSUBCONTINENT EXCLUSIVE:
You wouldn&t expect a medical app to get its start as aSnapchat competitor
Neither did video chat startup TapTalk founder Onno Faber
But four years ago he was diagnosed with a rare disease calledneurofibromatosistype 2 that caused tumors, leading Onno to lose hearing in
He amongst the one in 10 people with an uncommon health condition suffering from the lack of data designed to invent treatments for their
And he now the co-founder of RDMD.Emerging from stealth today, RDMD aggregates and analyzes medical records and sells the de-identified data
to pharmaceutical companies to help them develop medicines
In exchange for access to the data, patients gets their fragmented medical records organized into an app they can use to track their
treatment and get second opinions
It like Flatiron Health, the Google-backed cancer data startup that just got bought for $2 billion, but for rare diseases.Now RDMD is
announcing it raised a $3 million seed round led by Lux Capital and joined by Village Global, Shasta, Garuda, First Round Healthcare Coop
and a ton of top healthtech angels, including Flatiron investors and board members
The cash will help RDMD expand to build out its product and address more rare diseases.RDMD founders (from left): Nancy Yu and Onno Faber&We
believe that the traditional way rare disease RD is done needs to change,& RDMD CEO Nancy Yu tells TechCrunch
The former head of corp dev at 23andMe explains that, &There are over 7,000 rare diseases and growing, yet
